Literature DB >> 23307352

[Hypotonia in the neonatal period: 12 years' experience].

Erika Jiménez1, Àngels García-Cazorla, Jaume Colomer, Andrés Nascimento, Martín Iriondo, Jaume Campistol.   

Abstract

INTRODUCTION: Hypotonia is one of the most frequent signs of neurological pathology in newborn infants. AIMS: To determine, in a 12-year retrospective study, the relative frequency of neurological pathologies that can be accompanied by hypotonia during the neonatal period and to describe the neurological development after two years' follow-up. PATIENTS AND METHODS: We conducted a systematic review of the newborn infants with hypotonia due to an identifiable cause who were admitted to the neonatal unit of the Hospital Sant Joan de Deu between January 1996 and December 2008. Information collected referred to family history, data related with the pregnancy and childbirth, clinical features and complementary tests. RESULTS. A total of 73 hypotonic newborn infants were identified, 21 (28.7%) of whom met eligibility criteria. The majority, 81% (n = 17), were classified as central hypotonias and the remaining 19% (n = 4) were graded as peripheral hypotonias. In the first group, 47% (n = 8) presented chromosomal disorders, 29.4% (n = 5) had metabolic diseases and 23.5% (n = 4) displayed malformations of the central nervous system.
CONCLUSIONS: The central causes of hypotonia continue to be the most prevalent in the neonatal period and, within these, chromosomal disorders are the most frequent. Peripheral causes are less common and have a more severe prognosis. Advances in molecular genetics have allowed many neuromuscular diseases to be diagnosed both genetically and at the molecular level. The diversity and complexity of the pathologies justifies a multidisciplinary approach being taken to treat these newborn infants.

Entities:  

Mesh:

Year:  2013        PMID: 23307352

Source DB:  PubMed          Journal:  Rev Neurol        ISSN: 0210-0010            Impact factor:   0.870


  2 in total

1.  Frequency and Causes of Hypotonia in Neonatal Period with the Gestational Age of More Than 36 Weeks in NICU of Mofid Children Hospital, Tehran, Iran During 2012-2014.

Authors:  Nosratollah Seyed Shahabi; Hossain Fakhraee; Mohammad Kazemian; Abolfazl Afjeh; Minoo Fallahi; Maryam Shariati; Fatemeh Gorji
Journal:  Iran J Child Neurol       Date:  2017

2.  Utility of metabolic screening in neurological presentations of infancy.

Authors:  Djurdja Djordjevic; Etsuko Tsuchiya; Megan Fitzpatrick; Neal Sondheimer; James J Dowling
Journal:  Ann Clin Transl Neurol       Date:  2020-06-04       Impact factor: 4.511

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.